Source - LSE Regulatory
RNS Number : 6801B Optima Health PLC 21 March 2025 21 March 2025 Optima Health plc ("Optima Health" or the "Company") Director / PDMR Shareholding Optima Health plc (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, announces that it was notified on 20 March 2025, that Jonathan Thomas, (Chief Executive Officer of the Company) purchased 1,250 ordinary shares of £0.01 in the Company ("Ordinary Shares") at a price of 197.69 pence per share. In addition, Jonathan Thomas purchased a further 8 shares at 197.5p per share on 20 March 2025. This follows the discovery of an administrative error that resulted in the sale by Jonathan Thomas of 8 shares on 11 March 2025 at 182p per share. Following these transactions, Jonathan Thomas holds an interest in the Company of 218,356 Ordinary Shares, representing approximately 0.25% of the current issued share capital. Contacts: About Optima Health Optima Health is the UK's leading provider of occupational health and wellbeing services, directly influencing and improving people's lives for 25 years. Optima Health's incredible team of professionals quickly and effectively encapsulate client's needs, supporting organisations of all shapes and sizes. Through tailored solutions and innovative systems, Optima Health offers unparalleled clinical expertise to its clients. These solutions ensure that processes are simple and allow its clients to spend more time focusing on their employees driving a healthy, high-performing workplace. For more information visit www.optima health.co.uk NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHKFLBLEXLLBBQ